Side-by-side comparison of AI visibility scores, market position, and capabilities
Basildon UK global ag equipment (NYSE: CNH) at $18B+ agricultural revenue with New Holland/Case IH brands in 170 countries; Exor/Agnelli family control competing with Deere and AGCO for agricultural machinery markets.
CNH Industrial is a Basildon, United Kingdom-headquartered global agricultural and construction equipment manufacturer — controlled by Exor (the Agnelli family investment company) and listed on the New York Stock Exchange (NYSE: CNH) — providing farmers, contractors, and construction companies worldwide with agricultural machinery (tractors, combines, harvesters, balers) under the New Holland Agriculture, Case IH, and Steyr brands, and construction equipment under the Case CE and New Holland Construction brands. With $18+ billion in agricultural equipment revenue, 35,000+ employees across 40 production sites and 49 R&D centers, and market presence in approximately 170 countries, CNH Industrial is the world's second-largest agricultural machinery manufacturer by revenue. Formed in 2013 from the merger of Fiat Industrial and CNH Global.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.